61
Participants
Start Date
September 13, 2023
Primary Completion Date
March 30, 2026
Study Completion Date
March 30, 2026
M1774
In Phase 1b, M1774 will be administered as dosing regimen 1 or dosing regimen 2 until disease progression, death discontinuation criteria or any other reason. The selected dosing regimen of M1774 will be administered in all arms of Phase 2a.
Cemiplimab
Cemiplimab will be administered as an intravenous infusion every 3 weeks in all arms of Phase 1b and Phase 2a until disease progression, death discontinuation criteria or any other reason.
UPMC Cancer Center, Pittsburgh
Virginia Cancer Specialists, PC, Fairfax
Tennessee Cancer Specialists - Biomedical Research, Knoxville
The University of Texas MD Anderson Cancer Center, Houston
Millennium Research & Clinical Development, Houston
UCLA Hematology and Oncology - Santa Monica, Santa Monica
Institut Jules Bordet - Department of Institut Jules Bordet', Anderlecht
UZA - Oncology, Edegem
Jessa Ziekenhuis Hospital, Hasselt
Universitair Ziekenhuis Brussel - UZB, Jette
UZ Leuven, Leuven
CHU de Liège - PARENT, Liège
CHU Angers - Hôpital Larrey - Service de Pneumologie, Angers
Centre Hospitalier Intercommunal de Créteil - Service de Pneumologie, Créteil
CHU Limoges - Hôpital Dupuytren - Unite d'Oncologie Thoracique et Cutanée, Limoges
Hôpital de la Timone - CPCEM CIC - Bat F 1er étage, Marseille
Hopital Arnaud de Villeneuve - Service de Pneumologie-Addictologie, Montpellier
Groupe Hospitalier Sud - Hôpital Haut-Lévêque - Unité d'Explorations Fonctionnelles Respiratoires, Pessac
ICO - Site René Gauducheau - Service d'Oncologie medicale, Saint-Herblain
Universitaetsklinikum Giessen und Marburg GmbH - Medizinische Klinik und Poliklinik III, Giessen
Universitaetsklinikum Leipzig AoeR - Med. Klinik u. Poliklinik I - Abt. Pneumologie, Leipzig
Sana Klinikum Offenbach GmbH - Medizinische Klinik IV, Offenbach
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS - U.O. Oncologia Medica, Bologna
IEO Istituto Europeo di Oncologia - Divisione Oncologia Medica, Milan
Ospedale San Raffaele - U.O. di Oncologia Medica, Milan
Istituto Nazionale Tumori Fondazione G. Pascale - Medical Oncology Thoraco-Pulmonary Department, Napoli
Istituto Nazionale Tumori Regina Elena IRCCS - S.C. Oncologia Medica B, Roma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica, Rome
Istituto Clinico Humanitas - U.O. di Oncologia Medica ed Ematologia, Rozzano
National Cancer Center Hospital, Chūōku
Kansai Medical University Hospital, Hirakata-shi
National Cancer Center Hospital East, Kashiwa-shi
Cancer Institute Hospital of JFCR, Kōtoku
Kurume University Hospital, Kurume-shi
Aichi Cancer Center Hospital, Nagoya
Kindai University Hospital, Osakasayama-shi
Kanagawa Cancer Center, Yokohama
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Severance Hospital, Yonsei University Health System - Division of Infectious Diseases, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Hospital Clinic de Barcelona - Servicio de Oncologia, Barcelona
Hospital Universitari Vall d'Hebron - Oncology Dept., Barcelona
Hospital Universitario Reina Sofia - Dept of Oncology, Córdoba
Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica, Madrid
Hospital Universitario 12 de Octubre - Servicio de Oncologia, Madrid
Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia, Madrid
Hospital Universitario La Paz - Oncology Department, Madrid
Hospital Universitario Ramon y Cajal - Servicio de Oncologia, Madrid
Hospital Regional Universitario de Malaga - Oncology Dept, Málaga
Hospital Universitario Nuestra Señora de Valme - Servicio de Oncologia, Seville
Hospital Universitario Virgen del Rocio - Oncology Service, Seville
Hospital Universitario Virgen Macarena - Oncology Service, Seville
Hospital Universitari i Politecnic La Fe - Oncology Department, Valencia
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono Research & Development Institute, Inc.
INDUSTRY